A股異動 | 南洋股份(002212.SZ)漲近7% 證券簡稱擬變更為“天融信” 業務聚焦網絡安全領域
格隆匯10月12日丨南洋股份(002212.SZ)現報25.45元,漲6.93%,暫成交3.7億元,最新總市值296億元。南洋股份近日發公告稱,因公司主營業務變更,為聚焦業務於網絡安全領域,提升資產質量及效益,增強可持續經營能力,擬變更公司名稱為“天融信科技集團股份有限公司”,證券簡稱擬變更為“天融信”。公司表示,未來將不再從事電線電纜業務,將全面聚焦業務於網絡安全領域,有望在網絡安全行業景氣度不斷提升的大背景下,實現網絡安全領域營收規模及淨利潤規模的雙提升,優化並提高上市公司的盈利能力,提高公司在網絡安全行業的市場競爭力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.